Home | Business News | CBJ Newsmakers | Resverlogix Announces Ninth Positive Data Safety Monitoring Board Recommendation for Phase 3 Study of Apabetalone Resverlogix Announces Ninth Positive Data Safety Monitoring Board Recommendation for Phase 3 Study of Apabetalone CBJ Newsmakers RecommendedHigh Arctic Announces 2022 Second Quarter Financial and Operating ResultsMenē Inc. Announces Signing of Asset Purchase AgreementField Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing
